Terms: = Prostate cancer AND PTPRC, LCA, 5788, ENSG00000081237, T200, GP180, B220, LY5, CD45 AND Prognosis
14 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. Rapid and efficient capturing of circulating tumor cells from breast cancer Patient's whole blood via the antibody functionalized microfluidic (AFM) chip.
Abdulla A; Zhang Z; Ahmad KZ; Warden AR; Li H; Ding X
Biosens Bioelectron; 2022 Apr; 201():113965. PubMed ID: 35016111
[TBL] [Abstract] [Full Text] [Related]
3. Database Mining of Genes of Prognostic Value for the prostate Adenocarcinoma Microenvironment Using the cancer Gene Atlas.
Zhao X; Hu D; Li J; Zhao G; Tang W; Cheng H
Biomed Res Int; 2020; 2020():5019793. PubMed ID: 32509861
[TBL] [Abstract] [Full Text] [Related]
4. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
[TBL] [Abstract] [Full Text] [Related]
5. Analogous detection of circulating tumor cells using the AccuCyte
van der Toom EE; Groot VP; Glavaris SA; Gemenetzis G; Chalfin HJ; Wood LD; Wolfgang CL; de la Rosette JJMCH; de Reijke TM; Pienta KJ
Prostate; 2018 Mar; 78(4):300-307. PubMed ID: 29285777
[TBL] [Abstract] [Full Text] [Related]
6. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with prostate cancer prognosis.
Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
[No Abstract] [Full Text] [Related]
7. Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse.
Nardone V; Botta C; Caraglia M; Martino EC; Ambrosio MR; Carfagno T; Tini P; Semeraro L; Misso G; Grimaldi A; Boccellino M; Facchini G; Berretta M; Vischi G; Rocca BJ; Barone A; Tassone P; Tagliaferri P; Del Vecchio MT; Pirtoli L; Correale P
Cancer Biol Ther; 2016 Nov; 17(11):1213-1220. PubMed ID: 27791459
[TBL] [Abstract] [Full Text] [Related]
8. Development of a Novel c-MET-Based CTC Detection Platform.
Zhang T; Boominathan R; Foulk B; Rao C; Kemeny G; Strickler JH; Abbruzzese JL; Harrison MR; Hsu DS; Healy P; Li J; Pi C; Prendergast KM; Hobbs C; Gemberling S; George DJ; Hurwitz HI; Connelly M; Garcia-Blanco MA; Armstrong AJ
Mol Cancer Res; 2016 Jun; 14(6):539-47. PubMed ID: 26951228
[TBL] [Abstract] [Full Text] [Related]
9. Prediction model for early biochemical recurrence after radical prostatectomy based on the cancer of the prostate Risk Assessment score and the presence of secondary circulating prostate cells.
Murray NP; Aedo S; Reyes E; Orellana N; Fuentealba C; Jacob O
BJU Int; 2016 Oct; 118(4):556-62. PubMed ID: 26507242
[TBL] [Abstract] [Full Text] [Related]
10. Detection and quantification of CSF malignant cells by the CellSearch technology in patients with melanoma leptomeningeal metastasis.
Le Rhun E; Tu Q; De Carvalho Bittencourt M; Farre I; Mortier L; Cai H; Kohler C; Faure GC
Med Oncol; 2013 Jun; 30(2):538. PubMed ID: 23504338
[TBL] [Abstract] [Full Text] [Related]
11. Circulating fibroblast-like cells in men with metastatic prostate cancer.
Jones ML; Siddiqui J; Pienta KJ; Getzenberg RH
Prostate; 2013 Jan; 73(2):176-81. PubMed ID: 22718300
[TBL] [Abstract] [Full Text] [Related]
12. Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer.
Poveda A; Kaye SB; McCormack R; Wang S; Parekh T; Ricci D; Lebedinsky CA; Tercero JC; Zintl P; Monk BJ
Gynecol Oncol; 2011 Sep; 122(3):567-72. PubMed ID: 21664658
[TBL] [Abstract] [Full Text] [Related]
13. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
[TBL] [Abstract] [Full Text] [Related]
14. [Non-Hodgkin's lymphoma of the prostate: a report of 2 cases and review of the literature].
Shen XJ; Zheng XG; Zhou XJ; Zhou HB
Zhonghua Nan Ke Xue; 2007 Oct; 13(10):895-8. PubMed ID: 17977320
[TBL] [Abstract] [Full Text] [Related]
